SURVYR

VanEck Biotech ETF (BBH)
As of Jun 30, 2026, filed Aug 26, 2026. Holdings may be out of date: funds report them to the SEC quarterly, with a lag.SEC filing ↗All ETF tools

BBH holds 24 positions; the top 10 are 70.3% of the fund. The largest is Amgen Inc at 15.2%. Biggest sector: Health Care (70%).

Largest holding
15.2%
AMGN
Top 10 holdings
70.3%
of the fund
Holdings
24
net assets $395.6M
Biggest sector
70%
Health Care

Top 24 holdings

Largest first, as a share of the fund. Tap a stock for its SURVYR. page.

#Holding% of fund
1Amgen IncAMGN · Health Care15.25%
2Gilead Sciences IncGILD · Health Care12.79%
3Vertex Pharmaceuticals IncVRTX · Health Care9.10%
4Regeneron Pharmaceuticals IncREGN · Health Care6.21%
5Revolution Medicines IncRVMD · Healthcare5.27%
6Argenx SEARGX · Healthcare4.97%
7Natera IncNTRA · Healthcare4.92%
8IQVIA Holdings IncIQV · Health Care4.31%
9
Alnylam Pharmaceuticals IncALNY
3.83%
10Biogen IncBIIB · Health Care3.63%
11Moderna IncMRNA · Health Care3.36%
12Illumina IncILMN · Health Care3.17%
13United Therapeutics CorpUTHR · Health Care2.83%
14
BeOne Medicines LtdONC
2.81%
15Insmed IncINSM · Biotech & Healthcare2.67%
16Incyte CorpINCY · Health Care2.49%
17Neurocrine Biosciences IncNBIX · Health Care2.08%
18BioNTech SEBNTX · Healthcare1.94%
19Icon PLCICLR · Healthcare1.90%
20Bio-Techne CorpTECH · Health Care1.54%
21Charles River Laboratories International IncCRL · Health Care1.50%
22BioMarin Pharmaceutical IncBMRN · Health Care1.34%
23Qiagen NVQGEN · Healthcare1.06%
24Tempus AI IncTEM · Healthcare0.98%

Full list on SEC ↗ · All SEC filings

Cash and derivatives

Grouped, not listed one by one. Futures and swaps count at their gain or loss, not their full exposure.

Cash and money market1 line0.06%

Sectors

Share of the fund in each sector; holdings we can’t match are in “Other / unmapped”.

Health Care 69.6%Healthcare 21.1%Biotech & Healthcare 2.7%Other / unmapped 6.6%Cash 0.1% 70%Health Care
Health Care69.6%
Healthcare21.1%
Biotech & Healthcare2.7%
Other / unmapped6.6%
Cash0.1%

Overlap with SURVYR. portfolios

How much of BBH, by weight, is in stocks each portfolio holds today.

SURVYR. Long Book10.2%
2 of its 28 stocks are in BBH (RVMD, ARGX). 8% of the portfolio is in BBH names.
Quality Growth2.5%
1 of its 15 stocks are in BBH (INCY). 7% of the portfolio is in BBH names.
Momentum Top 153.4%
1 of its 15 stocks are in BBH (MRNA). 7% of the portfolio is in BBH names.
Momentum Blend3.4%
1 of its 21 stocks are in BBH (MRNA). 5% of the portfolio is in BBH names.
New Highs Growth5.3%
1 of its 25 stocks are in BBH (RVMD). 4% of the portfolio is in BBH names.
SURVYR. Barbell Momentum & T-Bill Shield2.7%
1 of its 16 stocks are in BBH (INSM). 5% of the portfolio is in BBH names.
SURVYR. Physical AI Grid & Power0.0%
No shared holdings.

Compare

Compare BBH with SPY or other funds: costs, past returns and shared holdings. BBH price chart · Compare stocks instead

How this works & disclosures

Source: VanEck Biotech ETF’s Form NPORT-P for the period ending Jun 30, 2026, filed with the SEC on Aug 26, 2026. Weights are each holding’s value as a share of the fund’s net assets on that date; cash, futures and swaps are grouped. Tickers and sectors are matched by SURVYR. and may be missing for some holdings. Overlap with SURVYR. portfolios is the share of the fund, by weight, in stocks each portfolio holds today.

Data from SEC Form N-PORT, the holdings report funds file with the SEC each quarter; the SEC makes it public about 60 days after the quarter ends. Holdings change; this may be out of date. SURVYR. describes what funds hold and how they have done; it does not manage money or give advice. Not investment advice. Full disclosures

Data from SEC filings. Holdings change; this may be out of date. Not investment advice. Disclosures

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026